SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551163-16-000549
Filing Date
2016-11-21
Accepted
2016-11-21 14:37:54
Documents
30
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 f10qseptember302016edgarjiev.htm 10-Q 239625
2 exhibit311.htm EX-31 8751
3 exhibit312.htm EX-31 8785
4 exhibit321.htm EX-32 4065
5 exhibit322.htm EX-32 4045
  Complete submission text file 0001551163-16-000549.txt   673225

Data Files

Seq Description Document Type Size
6 prtt-20160930.xml EX-101.INS 32467
7 prtt-20160930.xsd EX-101.SCH 8630
8 prtt-20160930_cal.xml EX-101.CAL 13008
9 prtt-20160930_def.xml EX-101.DEF 6144
10 prtt-20160930_lab.xml EX-101.LAB 51635
11 prtt-20160930_pre.xml EX-101.PRE 40387
Mailing Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109
Business Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109 8013223401
PROTECT PHARMACEUTICAL Corp (Filer) CIK: 0001493526 (see all company filings)

IRS No.: 271877179 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54001 | Film No.: 162010039
SIC: 2834 Pharmaceutical Preparations